NEUE Form 4: NEA-managed warrants exercised, shares rolled into parent
Rhea-AI Filing Summary
NeueHealth, Inc. (NEUE) Form 4 filed for 10/02/2025 reports multiple related transactions by Carmen Chang, a director and reported 10% owner through NEA-managed entities. The filing shows a sequence of warrant exercises, cashless net exercises and share cancellations tied to a merger: totals include the acquisition or conversion of warrants and preferred interests aggregating to 2,384,873 common-stock-equivalent shares reported then cancelled in connection with a rollover into a new parent and merger. Several warrants were exercised at an effective price of $0.01 or net-settled using a closing price of $6.75. The Form 4 discloses that contributed shares, Series A and B preferred positions and warrants were exchanged for limited partnership interests in the Ultimate Parent and subsequently cancelled as part of the Merger closing on 10/02/2025.
Positive
- Transparent disclosure of multiple related-party exercises and cancellations on 10/02/2025
- Warrants exercised and net-settled using a clearly stated fair market value of $6.75
Negative
- Large cancellations of common and preferred shares totaling 2,384,873 common-stock equivalents, which change public float calculations
- Complex ownership routed through multiple NEA entities may reduce clarity of individual economic interest for some investors
Insights
Director's holdings reorganized into merger rollover; large cancellations reported.
The reporting person acts as manager for multiple NEA entities that held common stock, Series A and Series B preferred stock and warrants that were contributed to Ultimate Parent in exchange for limited partnership interests as part of the merger consideration on 10/02/2025.
This filing documents corporate control reorganization rather than open-market trading; key dependencies include the terms of the rollover agreements and the merger agreement that caused the reported cancellations. Investors can monitor any future disclosures about ownership percentages in the Ultimate Parent and any related lockups or transfer restrictions within the next several quarters.
Large warrant exercises and cashless net settlements materially changed reported beneficial interests.
The Form 4 shows warrant exercises at an exercise price of $0.01 and cashless net exercises using a $6.75 FMV to determine surrendered shares, producing multiple allotments and net disposals across NEA-related holders totaling common-stock-equivalents in the low millions.
Reported conversions and cancellations tied to the Merger removed those underlying shares from public company capitalization on 10/02/2025. Watch for periodic filings that disclose the Ultimate Parent's stake or any subsequent sales or registrations over the next 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Warrant (Right to Buy) | 189,195 | $0.00 | $0.00 |
| Grant/Award | Warrant (Right to Buy) | 372,255 | $0.00 | $0.00 |
| Exercise | Warrant (Right to Buy) | 372,255 | $0.00 | $0.00 |
| In-the-Money Exercise | Warrant (Right to Buy) | 189,195 | $0.00 | $0.00 |
| Grant/Award | Warrant (Right to Buy) | 186,128 | $0.00 | $0.00 |
| Exercise | Warrant (Right to Buy) | 186,128 | $0.00 | $0.00 |
| Disposition | Series A Convertible Perpetual Preferred Stock | 75,000 | $0.00 | $0.00 |
| Disposition | Series B Convertible Perpetual Preferred Stock | 37,700 | $0.00 | $0.00 |
| In-the-Money Exercise | Warrant (Right to Buy) | 1,656,789 | $0.00 | $0.00 |
| In-the-Money Exercise | Warrant (Right to Buy) | 607,536 | $0.00 | $0.00 |
| Grant/Award | Warrant (Right to Buy) | 124,085 | $0.00 | $0.00 |
| Exercise | Warrant (Right to Buy) | 124,085 | $0.00 | $0.00 |
| Disposition | Series A Convertible Perpetual Preferred Stock | 125,000 | $0.00 | $0.00 |
| Disposition | Series B Convertible Perpetual Preferred Stock | 100,000 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock | 189,195 | $0.01 | $2K |
| Sale | Common Stock | 280 | $6.75 | $2K |
| Exercise | Common Stock | 372,255 | $0.01 | $4K |
| Exercise Price or Tax Liability | Common Stock | 551 | $6.75 | $4K |
| Disposition | Common Stock | 1,159,683 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock | 189,195 | $0.01 | $2K |
| Sale | Common Stock | 280 | $6.75 | $2K |
| Exercise | Common Stock | 186,128 | $0.01 | $2K |
| Exercise Price or Tax Liability | Common Stock | 276 | $6.75 | $2K |
| Disposition | Common Stock | 674,554 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock | 1,656,789 | $0.01 | $17K |
| Sale | Common Stock | 2,455 | $6.75 | $17K |
| In-the-Money Exercise | Common Stock | 607,536 | $0.01 | $6K |
| Sale | Common Stock | 900 | $6.75 | $6K |
| Exercise | Common Stock | 124,085 | $0.01 | $1K |
| Exercise Price or Tax Liability | Common Stock | 182 | $6.75 | $1K |
| Disposition | Common Stock | 2,384,873 | $0.00 | $0.00 |
Footnotes (12)
- F1. The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.
- F2. Represents the cashless net exercise of a warrant through the surrender of shares to the Issuer based on a fair market value of $6.75 per share, the closing market price of the Issuer's common stock on October 1, 2025.
- F3. Pursuant to the Agreement and Plan of Merger, dated as of December 23, 2024, by and among the Issuer, NH Holdings 2025, Inc. ("Parent") and NH Holdings Acquisition 2025, Inc. ("Merger Sub"), on October 2, 2025, Merger Sub merged with and into the Issuer with the Issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to rollover agreements entered into between certain of the Reporting Persons and NH Holdings 2025 SPV, L.P. ("Ultimate Parent"), Parent and Merger Sub, each share of the Issuer's Common Stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") beneficially owned by the Reporting Persons was contributed to Ultimate Parent in exchange for limited partnership interests in Ultimate Parent. Each such share of the Issuer's Common Stock, Series A Preferred Stock and Series B Preferred Stock was then cancelled and ceased to exist.
- F4. The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
- F5. The Reporting Person is a manager of NEA 18 VGE GP, LLC, which is the sole general partner of NEA Partners 18 VGE, L.P. ("NEA Partners 18 VGE"). NEA Partners 18 VGE is the sole general partner of NEA 18 Venture Growth Equity, L.P. ("NEA 18 VGE"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 18 VGE in which the Reporting Person has no pecuniary interest.
- F6. The warrants became exercisable as to 123,729 shares on April 30, 2024, 1,733 shares on June 21, 2024, 61,865 shares on October 2, 2024 and 1,868 shares on September 26, 2025.
- F7. Warrants issued pursuant to the Warrantholders Agreement, dated September 30, 2025 between the Issuer and the holders listed on Schedule 1 thereto, and the Credit Agreement, dated August 4, 2023, as amended by that certain Incremental Amendment No. 1, dated as of October 2, 2023, that certain Incremental Amendment No. 2, dated as of April 8, 2024, that certain Amendment No. 3, dated as of June 21, 2024, that certain Amendment No. 4, dated as of October 29, 2024, and that certain Amendment No. 5, dated as of September 30, 2025, between the Issuer and the lenders thereto.
- F8. The warrants became fully exercisable on October 2, 2025.
- F9. The Series A Preferred Stock was convertible into the number of shares of the Issuer's Common Stock equal to the quotient of (a) the sum of (i) the liquidation preference (initially $1,000 per share) plus (ii) the accrued dividends thereon as of the conversion date, divided by (b) the conversion price (initially approximately $4.55 per share) as of the conversion date, subject to anti-dilution adjustments. The Series A Preferred Stock was convertible at any time and had no expiration date, subject to the Issuer's election to convert or redeem all of the Series A Preferred Stock upon the occurrence of certain conditions.
- F10. The Series B Preferred Stock was convertible into the number of shares of the Issuer's Common Stock equal to the quotient of (a) the sum of (i) the liquidation preference (initially $1,000 per share) plus (ii) the accrued dividends thereon as of the conversion date, divided by (b) the conversion price (initially approximately $1.4169 per share) as of the conversion date, subject to anti-dilution adjustments. The Series B Preferred Stock was convertible at any time and had no expiration date, subject to the Issuer's election to convert or redeem all of the Series B Preferred Stock upon the occurrence of certain conditions.
- F11. The warrants became exercisable as to 828,395 shares on August 29, 2023, 552,263 shares on September 18, 2023, 100,606 shares on November 1, 2023 and 175,525 shares on December 20, 2023.
- F12. The warrants became exercisable as to 371,187 shares on April 30, 2024, 28,399 shares on June 21, 2024, 185,595 shares on October 2, 2024 and 22,355 shares on September 26, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.